Suppr超能文献

卵巢低分化伴异源成分的支持-间质细胞瘤

Poorly Differentiated Sertoli-Leydig Cell Tumour of Ovary with Heterologous Elements.

作者信息

Sahoo Tapan Kumar, Kar Tushar, Kar Asaranti, Panda Sasmita

机构信息

Senior Resident, Department of Radiation Oncology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.

Professor, Department of Obstetrics and Gynaecology, Sriram Chandra Bhanja Medical College, Cuttack, Odisha, India.

出版信息

J Clin Diagn Res. 2017 May;11(5):XD01-XD02. doi: 10.7860/JCDR/2017/25262.9860. Epub 2017 May 1.

Abstract

Sertoli-Leydig Cell Tumour (SLCT) is included under sex-cord stromal tumour of testis or ovary. Ovarian pathology is an extremely rare entity constituting less than 0.5% of all ovarian neoplasms. Majority of the cases present at younger age group, i.e., 2 and 3 decade of life. The clinical presentation depends on either mass effect or excess hormone production. Virillization symptoms are the most common presentation and depend upon the quantity of androgen production. Most of the patients have a unilateral mass without extraovarian spread and present at stage-I. Treatment and prognosis depends on the degree of the differentiation and the stage of the disease. Here, we report a case of SLCT of the ovary in a young female. The patient initially presented with pain abdomen due to mass effect and was treated with conservative surgery followed by adjuvant chemotherapy due to the presence of poorly differentiated pathology with heterologous elements.

摘要

支持-间质细胞瘤(SLCT)包含在睾丸或卵巢的性索间质肿瘤中。卵巢病理情况是一种极其罕见的实体,占所有卵巢肿瘤的比例不到0.5%。大多数病例出现在较年轻的年龄组,即20和30岁年龄段。临床表现取决于肿块效应或激素过度分泌。男性化症状是最常见的表现,取决于雄激素的分泌量。大多数患者有单侧肿块,无卵巢外扩散,处于I期。治疗和预后取决于分化程度和疾病分期。在此,我们报告一例年轻女性卵巢SLCT病例。患者最初因肿块效应出现腹痛,接受了保守手术治疗,由于存在伴有异源性成分的低分化病理情况,随后接受了辅助化疗。

相似文献

1
Poorly Differentiated Sertoli-Leydig Cell Tumour of Ovary with Heterologous Elements.
J Clin Diagn Res. 2017 May;11(5):XD01-XD02. doi: 10.7860/JCDR/2017/25262.9860. Epub 2017 May 1.
2
Sertoli-leydig cell tumour of ovary with menorrhagia: a rare case report.
J Clin Diagn Res. 2014 Oct;8(10):FD18-20. doi: 10.7860/JCDR/2014/9394.5014. Epub 2014 Oct 20.
3
Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors.
Oncologist. 2019 May;24(5):702-709. doi: 10.1634/theoncologist.2017-0632. Epub 2018 Sep 10.
4
Mucinous adenocarcinoma as heterologous element in intermediately differentiated Sertoli-Leydig cell tumor of the ovary.
Pathol Res Pract. 2010 Jul 15;206(7):489-92. doi: 10.1016/j.prp.2009.07.012. Epub 2009 Aug 11.
5
Sertoli-leydig cell tumor of ovary- a diagnostic dilemma.
J Clin Diagn Res. 2014 Mar;8(3):127-9. doi: 10.7860/JCDR/2014/7000.4099. Epub 2014 Mar 15.
7
Sertoli-Leydig cell tumor of the ovary: Analysis of a single institution database and review of the literature.
J Obstet Gynaecol Res. 2019 Jul;45(7):1311-1318. doi: 10.1111/jog.13977. Epub 2019 May 20.
8
A Sertoli-Leydig ovarian tumor presenting as ovarian torsion: A case report.
Case Rep Womens Health. 2024 May 9;42:e00614. doi: 10.1016/j.crwh.2024.e00614. eCollection 2024 Jun.
9
Ovarian Sertoli-Leydig tumor: A tricky tumor case report.
Int J Surg Case Rep. 2023 Apr;105:108043. doi: 10.1016/j.ijscr.2023.108043. Epub 2023 Mar 23.
10
[Sertoli-Leydig cell tumor of the ovary: case study of a 22-year old woman].
Pan Afr Med J. 2016 Sep 28;25:36. doi: 10.11604/pamj.2016.25.36.10469. eCollection 2016.

引用本文的文献

1
Fertility-Sparing Surgery for Ovarian Cancer.
J Clin Med. 2021 Sep 18;10(18):4235. doi: 10.3390/jcm10184235.
2
Spectrum of Germline Pathogenic Variants in Ovarian Sertoli-Leydig Cell Tumor.
J Clin Med. 2021 Apr 23;10(9):1845. doi: 10.3390/jcm10091845.
3
Ovarian Sertoli-Leydig Cell Tumors: Epidemiological, Clinical and Prognostic Factors.
Rev Bras Ginecol Obstet. 2019 Jul;41(7):440-448. doi: 10.1055/s-0039-1693056. Epub 2019 Jul 25.

本文引用的文献

1
Poorly differentiated ovarian sertoli-leydig cell tumor in a 16-year-old single woman: a case report and literature review.
Case Rep Obstet Gynecol. 2013;2013:858501. doi: 10.1155/2013/858501. Epub 2013 Jun 25.
2
Sertoli-Leydig cell tumors of the ovary: a Taiwanese Gynecologic Oncology Group study.
Taiwan J Obstet Gynecol. 2013 Mar;52(1):66-70. doi: 10.1016/j.tjog.2012.03.001.
3
A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors.
Gynecol Oncol. 2012 Nov;127(2):384-9. doi: 10.1016/j.ygyno.2012.07.114. Epub 2012 Jul 28.
4
Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study.
Gynecol Oncol. 2012 Jun;125(3):673-6. doi: 10.1016/j.ygyno.2012.03.024. Epub 2012 Mar 22.
5
Sertoli-Leydig cell tumor: a rare ovarian neoplasm. Case report and review of literature.
Gynecol Endocrinol. 2008 Apr;24(4):230-4. doi: 10.1080/09513590801953465.
6
Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
Semin Diagn Pathol. 2005 Feb;22(1):3-32. doi: 10.1053/j.semdp.2005.11.002.
8
A case of poorly differentiated Sertoli-Leydig tumor of the ovary.
J Pediatr Adolesc Gynecol. 2004 Feb;17(1):49-52. doi: 10.1016/j.jpag.2003.11.006.
9
Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases.
Am J Surg Pathol. 1985 Aug;9(8):543-69. doi: 10.1097/00000478-198508000-00001.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验